US OptionsDetailed Quotes
SAVA240726P17000
- 3.43
- -1.32-27.79%
15min DelayClose Jul 26 15:58 ET
3.90High3.43Low
3.90Open4.75Pre Close13 Volume39 Open Interest17.00Strike Price4.84KTurnover3870.76%IV9.05%PremiumJul 26, 2024Expiry Date2.08Intrinsic Value100Multiplier0DDays to Expiry1.35Extrinsic Value100Contract SizeAmericanOptions Type-0.6322Delta0.0919Gamma5.02Leverage Ratio-42.8727Theta0.0000Rho-3.17Eff Leverage0.0004Vega
Cassava Sciences Stock Discussion
Sign in to post a comment
$Cassava Sciences(SAVA.US$ Really Great News For Patients using Simufilam. Clinical trial sites are very excited about Simufilam. Key quotes from two phase 3 trial sites. Thanks Matt For updates:
6
1
$Cassava Sciences(SAVA.US$ This is Bullish News and shorts are just cheating / manipulating stock price . They will not stop people improving with Simufilam treating Alzheimer’s . Thanks Matt for Update
5
$Cassava Sciences(SAVA.US$ please rise
$Cassava Sciences(SAVA.US$ hop in lets fly 🚆 🚀 🚀
$Cassava Sciences(SAVA.US$ fly fly 🚀
No comment yet
70107211 : Jay, thank you so much for tirelessly provide the true information /news to us all the time!